Pharm Flashcards
easily pass through BBB
H20
gases (CO2, O2)
lipophilic/nonionized things
Duration of effect of lipophilic drug
crosses BBB easily, so in and out fast (short duration)
Elimination of lipophilic drug
goes to adipose tissue and stays there a while, so long elimination
P-gp transporter
= ABCB1 apical transporter
- antidepressants are a substrate
Depression and p-gp
- stress makes it harder for corticosteroids to exhibit negative fb by getting through BBB because depression limits p-gp activity
Excitatory NTs
glutamate
aspartate
(acidic AA’s)
Inhibitory NTs
GABA
glycine
B alanine
taurine
Where are NEs highest in concentration?
Hypothalamus
Amygdala
Dentate Gyrus of Hippocampus
Locus Ceruleus of Pons
Adrenergic pathways are important in…
sleep and arousal regulation
PTSD may be due to
Beta activation in amygdala
What pathways are involved in wakefulness?
Ach and NE
What is special about antipsychotics?
They don’t possess uniform receptor activation. Can have SE’s by modulating adrenergic, cholinergic, histaminergic, serotinergic receptors
Antidepressants MOA
typically block reuptake of 5HT, NE, or Dopamine
What’s special about the amygdala?
every NT acts here
high alpha1, beta1
Tx for intrusion component of PTSD
Beta blockers
Tx for hyperarousal component of PTSD
alpha blockers
L-DOPA/Levodopa
- for Parkinson’s
- replenishes DA stores in SNc
- orally, but inhibited by food
- converted in periphery and brain to DOPA by L-AAD (so given with Carbidopa to inhibit peripheral conversion, b/c that Dopa can’t cross BBB)
- AE alone: GI, CV (arrythmia’s, Orthosthypoten)
- AE with Carbidopa: behavioral (give antipsychotics) dyskinesias (hyper)
- single most effective treatment, BUT don’t use early b/c on-off phenom and gets exhausted in 3-5 yrs
- contra: psychotic, glaucoma, CV, PUD, melanoma, DDI with VitB6
General tx strategies for Parkinson’s
- replace Dopa
- stimulate D2 receptor with Dopa agonist
- inc. Dopa release
- inhibit Dopa metab
- alter DA/ACh balance
Apomorphine
- Dopa agonist for Parkinson’s
- good initial therapy
- nonselective
Bromocriptine
- Dopa agonist for Parkinson’s
- good initial therapy
- D2/D1 selectivity
Pramipexole
- Dopa agonist for Parkinson’s
- good initial therapy
- D2 selective
- free radical scavenger
Ropinirole
- Dopa agonist for Parkinson’s
- good initial therapy
- D2 selective, CYP1A2 metab
Amantadine
- for Parkinson’s
- antiviral that inc. Dopa release
- MOA unknown
- AE: psychotic, psychosis with OD
- contra: seizures and CHF
Selegiline
- MAO-B inhibitor for Parkinson’s
- very potent inhibitor of Dopa metab
- used when L-dopa starts to be less effective
- metabolized into amphetamine/methamphetamine
- DDI with Meperidine, TCAs, SSRIs